Cholinesterase inhibitor with nicotinic receptor allosteric modulator

This page covers all Cholinesterase inhibitor with nicotinic receptor allosteric modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Acetylcholinesterase; nicotinic acetylcholine receptors.

Targets

Acetylcholinesterase; nicotinic acetylcholine receptors

Marketed (1)

• Galantamine-CR · Massachusetts General Hospital · Neurology
  Galantamine is a cholinesterase inhibitor that increases acetylcholine levels in the brain by blocking its breakdown, and also acts as an allosteric modulator of nicotinic receptors.

Patent intelligence

• cholinesterase inhibitor with nicotinic receptor allosteric modulator patent landscape — aggregated cliff calendar, attackable patents, originator estates